Paper Details

  1. Home
  2. Paper Details

Prevalence of cutaneous adverse events associated with long-term disease-modifying therapy and their impact on health-related quality of life in patients with multiple sclerosis: a cross-sectional study.

Author: BalakDeepak M W, HajdarbegovicEnes, HengstmanGerald J D, HuppertsRaymond M M, ThioHok Bing, van den BruleRob J P

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Glatiramer acetate (GA) and interferon-beta (IFN-β) are common treatments for multiple sclerosis. This study found that 56% of patients experience skin reactions associated with these treatments, with 20% experiencing significant impact on their quality of life.
Paper Details　
Original Abstract of the Article :
Glatiramer acetate (GA) and interferon-beta (IFN-β) are disease-modifying therapies (DMTs) for multiple sclerosis that are administered through subcutaneous (SC) or intramuscular (IM) injections. Skin reactions associated with DMTs are common and may influence patient's health-related quality of lif...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854544/

データ提供：米国国立医学図書館（NLM）

Skin Reactions and Quality of Life in Multiple Sclerosis

Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system. This cross-sectional study, published in Multiple Sclerosis Journal, investigated the prevalence of cutaneous adverse events associated with long-term disease-modifying therapies (DMTs) for MS and their impact on health-related quality of life (QoL).

Skin Reactions Impact Quality of Life

The study found that skin reactions associated with DMTs were common in MS patients and had a negative impact on QoL. Patients experiencing skin reactions reported lower levels of physical and mental well-being.

Managing Skin Reactions in MS

This study highlights the importance of recognizing and managing skin reactions in MS patients receiving DMTs. It emphasizes the need for strategies to minimize skin reactions and improve the overall QoL of patients undergoing long-term DMT treatment.

Dr.Camel's Conclusion

Navigating multiple sclerosis is like journeying through a desert of uncertainty, with the potential for unexpected challenges. This study reveals the impact of skin reactions on QoL in MS patients, highlighting the importance of addressing these side effects to improve the well-being of those living with this condition. Finding ways to mitigate skin reactions is like discovering a hidden spring in the desert, providing relief and supporting a more comfortable and fulfilling journey.
Date :
  1. Date Completed 2014-09-29
  2. Date Revised 2021-10-21
Further Info :

Pubmed ID

24131589

DOI: Digital Object Identifier

PMC3854544

Related Literature

Article Analysis
・Side Effects of glatiramer injection
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.